Bacterial infections have long been an ever-emerging problem with the appearance of antibiotic resistant bacteria which is deteriorating with the misuse and abuse of antibiotics. As infections of these emerging bacteria can hardly be treated, we are seeking a protective method to fight bacteria by the development of glycoconjugate vaccines. Chemical syntheses to obtain pure structures of the target antigens are essential for further glycobiology and immunity studies.
